Fox Run Management’s Celldex Therapeutics CLDX Stock Holding History

Fox Run Management’s Portfolio CLDX Stock Details CLDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$390K	Sell
2025 Q1	$593K	Buy
2024 Q4	$589K	Buy
2024 Q3	$317K	Buy
2024 Q2	–	Sell
2024 Q1	$202K	Sell
2023 Q4	$446K	Buy